Literature DB >> 10325508

Prostatic intraepithelial neoplasia: A marker for high-risk groups and a potential target for chemoprevention.

W A Sakr1.   

Abstract

Both the incidence of, and the mortality due to, prostate cancer in the USA are higher in African-American men than in Caucasian men. This is particularly true in men less than 60 years of age. Our findings indicate that both the prevalence and the extensiveness of high-grade prostatic intraepithelial neoplasia (PIN) are higher in African-American men compared to Caucasians and that this discrepancy starts as early as the third decade of life. In an autopsy series comprising 650 men, extensive high-grade PIN with diffuse involvement of the prostate gland was evident in 25 (7%) of 364 African-American men less than 50 years of age compared to 4 (2%) of 208 Caucasian men in the same age group (p = 0.002). In a series of more than 1,200 men undergoing radical prostatectomy for clinically localized prostate cancer, extensive high-grade PIN was significantly and consistently higher in the African-American cohort than the Caucasian cohort. The difference was more evident in younger patients and those with smaller, organ-confined tumors. In a subset of 216 men (71 African-Americans and 138 Caucasians) with clinical stage T1C prostate cancer, extensive high-grade PIN was identified in 33% and 12% of the two groups respectively (p = 0.001). Moreover, in patients with organ-confined disease, both Gleason score and the extensiveness of high-grade PIN were significant predictors of biochemical recurrence. Our findings suggest an important role for high-grade PIN in the development of clinically significant, potentially aggressive prostate cancer in African-American men. In this epidemiologically identifiable high-risk group, there is a potential opportunity for chemoprevention strategies in younger men with high-grade PIN.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10325508     DOI: 10.1159/000019882

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  10 in total

Review 1.  High grade prostatic intraepithelial neoplasia is a disease.

Authors:  M S Steiner
Journal:  Curr Urol Rep       Date:  2001-06       Impact factor: 3.092

2.  Prostatic intraepithelial neoplasia: an overview.

Authors:  Michael K Brawer
Journal:  Rev Urol       Date:  2005

3.  Drug therapies for eradicating high-grade prostatic intraepithelial neoplasia in the prevention of prostate cancer.

Authors:  Samir S Taneja
Journal:  Rev Urol       Date:  2005

Review 4.  [High-grade prostatic intraepithelial neoplasia: the only accepted prostate cancer precursor lesion].

Authors:  M Braun; S Perner
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

5.  Androgen induces adaptation to oxidative stress in prostate cancer: implications for treatment with radiation therapy.

Authors:  Jehonathan H Pinthus; Inna Bryskin; John Trachtenberg; Jiang-Ping Lu; Gurmit Singh; Eduard Fridman; Brian C Wilson
Journal:  Neoplasia       Date:  2007-01       Impact factor: 5.715

Review 6.  Precursor lesions to prostatic adenocarcinoma.

Authors:  Jonathan I Epstein
Journal:  Virchows Arch       Date:  2008-12-02       Impact factor: 4.064

Review 7.  High-grade prostatic intraepithelial neoplasia and prostate cancer risk reduction.

Authors:  Mitchell S Steiner
Journal:  World J Urol       Date:  2003-02-21       Impact factor: 4.226

8.  High grade prostate intraepithelial neoplasia (PIN) is a PSA-independent risk factor for prostate cancer in African American men: results from a pilot study.

Authors:  Ganna Chornokur; Gang Han; Richard Tanner; Hui-Yi Lin; B Lee Green; Julio Pow-Sang; Catherine M Phelan
Journal:  Cancer Lett       Date:  2012-12-23       Impact factor: 8.679

9.  Molecular Targeted Therapies Using Botanicals for Prostate Cancer Chemoprevention.

Authors:  Nagi Kumar; Ganna Chornokur
Journal:  Transl Med (Sunnyvale)       Date:  2012-12-31

10.  Apolipoprotein E gene polymorphism influences aggressive behavior in prostate cancer cells by deregulating cholesterol homeostasis.

Authors:  Godwin O Ifere; Renee Desmond; Wendy Demark-Wahnefried; Tim R Nagy
Journal:  Int J Oncol       Date:  2013-08-07       Impact factor: 5.650

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.